AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
59 hedge funds and large institutions have $36.2M invested in AVEO Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
62% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 21
Holders
59
Holding in Top 10
–
Calls
$3.19M
Puts
$2.09M
Top Buyers
| 1 | +$1.67M | |
| 2 | +$551K | |
| 3 | +$486K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$228K |
| 5 |
VF
Virtu Financial
New York
|
+$117K |
Top Sellers
| 1 | -$2.42M | |
| 2 | -$1.02M | |
| 3 | -$732K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$486K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$321K |